Phytoestrogens increase the capacity of serum to stimulate prostacyclin release in human endothelial cells

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 8, 2003, Pages 705-710

  García Martínez, María Cinta ^a   Hermenegildo, Carlos ^a   Tárin, Juan J ^a   Cano, Antonio ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Endothelial cells; Isoflavones; Postmenopausal women; Prostacyclin; Serum

Indexed keywords

ISOFLAVONE; PHYTOESTROGEN; PHYTOGYN; PROSTACYCLIN;

ADULT; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR EFFECT; CELL CULTURE; CLINICAL ARTICLE; CLOVER; CULTURE MEDIUM; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HYPOTHESIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SOYBEAN; UMBILICAL VEIN;

ADMINISTRATION, ORAL; BLOOD PHYSIOLOGY; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; PHYTOESTROGENS; PLANT EXTRACTS; PLANT PREPARATIONS; PLATELET AGGREGATION INHIBITORS; POSTMENOPAUSE; SOYBEANS; TIME FACTORS; TRIFOLIUM; UMBILICAL VEINS;

EID: 0041346251     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00178.x     Document Type: Article

References (32)

1. Ylikorkala O. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution. Acta Obstet Gynecol Scand 2000; 79: 1029-36.
2. Skouby S. Consequences for HRT following the HERS II and WHI reports: the primum non nocere is important, but translation into quo vadis is even more essential. Acta Obstet Gynecol Scand 2002; 81: 793-8.
3. Hulley S. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate. Can J Cardiol 2000; 16: 10E-12E.
4. Anonymous. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2002; 288: 321-33.
5. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs G et al., for the HERS Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc 1998; 280: 605-13.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326: 242-50.
7. Anggard EE. The endothelium - the body's largest endocrine gland? J Endocrinol 1990; 127: 371-5.
8. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
9. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11.
10. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 2000; 97: 5930-5.
11. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res 1998; 83: 224-9.
12. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-8.
13. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68: 1333S-46S.
14. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996; 126: 43-50.
15. Clarkson TB, Anthony MS. Phytoestrogens and coronary heart disease. Bailliere's Clin Endocrinol Metab 1998; 12: 589-604.
16. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001; 86: 41-7.
17. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 2001; 24: 351-6.
18. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
19. Mikkola T, Ristimaki A, Viinikka L, Ylikorkala O. Human serum, plasma, and platelets stimulate prostacyclin and endothelin-1 synthesis in human vascular endothelial cells. Life Sci 1993; 53: 283-9.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 196: 265-75.
21. Alexandersen P, Haarbo J, Breinholt V, Christiansen C. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis. Climacteric 2001; 4: 151-9.
22. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 2001; 38: S3-S6.
23. Durante W, Kroll MH, Vanhoutte PM, Schafer AI. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Blood 1992; 79: 110-16.
24. Durante W, Schini VB, Catovsky S, Kroll MH, Vanhoutte PM, Schafer AI. Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. Am J Physiol 1993; 264: H617-24.
25. Joswig M, Hach-Wunderle V, Ziegler R, Nawroth PP. Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 beta-estradiol's effects on vascular biology. Exp Clin Endocrinol Diabetes 1999; 107: 477-87.
26. Mikkola T, Ranta V, Orpana A, Ylikorkala O, Viinikka L. Effect of physiological concentrations of estradiol on PGI2 and NO in endothelial cells. Maturitas 1996; 25: 141-7.
27. Seeger H, Mueck AO, Lippert TH. Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures. Life Sci 1999; 65: L167-70.
28. Mikkola T, Ranta V, Orpana A, Viinikka L, Ylikorkala O. Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells. Fertil Steril 1996; 66: 389-93.
29. Mikkola T, Viinikka L, Ylikorkala O. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells. Fertil Steril 2000; 73: 72-4.
30. de Kleijn MJ, Der Schouw YT, Wilson PW, Grobbee DE, Jacques PF. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal U.S. women: The Framingham Study. J Nutr 2002; 132: 276-82.
31. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-82.
32. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B.